| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,295 | 3,400 | 12:16 | |
| 0,000 | 0,000 | 08:39 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10:20 | XFRA 6IV: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILINVENTIVA S.A.(PROM.)-... ► Artikel lesen | |
| 10:20 | XETR FR0013233012: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME Waehrung/Currency ISIN BIS/UNTILINVENTIVA S.A.(PROM.)-... ► Artikel lesen | |
| Mi | INVENTIVA: Inventiva announces launch of public offering | Daix (France), New York City (New York, United States), November 12, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused... ► Artikel lesen | |
| 06.11. | INVENTIVA: Statement of total voting rights and shares forming the company's share capital as October 20, 2025 | Article R. 22-10-23 of the French Commercial Code Market: Euronext ParisISIN code / Mnemo: FR0013233012 / IVAWeb site: www.inventivapharma.com
Date Number of Shares Outstanding
... ► Artikel lesen | |
| 06.11. | INVENTIVA: Combined General Meeting of November 27, 2025 - Availability of the preparatory documents | Daix (France), New York City (New York, United States), November 6, 2025 - Inventiva (Euronext Paris and Nasdaq: IVA) ("Inventiva" or the "Company"), a clinical-stage biopharmaceutical company focused... ► Artikel lesen |
